Abstract |
Interferon gamma (IFN-gamma) stimulates the (pro-inflammatory) type II interferon receptor and is known to exacerbate multiple sclerosis (MS). In contrast, IFN-alpha and IFN-beta are ligands for the (anti-inflammatory) type I interferon receptor and are beneficial in some (but not all) patients with MS. Should IFN-beta elicit a type-II-like pro-inflammatory response, the beneficial effects might be attenuated. These studies were undertaken to test this possibility with the use of quinolinic acid (QUIN) formation as a measure of type II receptor activation. In normal human macrophage cultures, IFN-gamma was the most potent stimulus for QUIN formation. Generally, IFN-beta and IFN-alpha were less potent. However, an unexpected inter-patient variability was observed. In some subjects, IFN-alpha was more potent than IFN-beta. In other subjects, IFN-beta was more potent than IFN-alpha. The present data demonstrate an inter-subject variability for QUIN production following exposure to the interferons. MS patients who demonstrate a pro-inflammatory response to IFN-beta (e.g., increased QUIN) may be less likely to benefit from this therapy.
|
Authors | M Jansen, J F Reinhard Jr |
Journal | Journal of leukocyte biology
(J Leukoc Biol)
Vol. 65
Issue 4
Pg. 439-43
(Apr 1999)
ISSN: 0741-5400 [Print] United States |
PMID | 10204571
(Publication Type: Journal Article)
|
Chemical References |
- Interferon-alpha
- Interferon-beta
- Interferon-gamma
|
Topics |
- Adult
- Cells, Cultured
- Female
- Humans
- Inflammation
(immunology)
- Interferon-alpha
(immunology, pharmacology)
- Interferon-beta
(immunology, pharmacology)
- Interferon-gamma
(immunology, pharmacology)
- Macrophages
- Male
- Monocytes
- Multiple Sclerosis
(immunology, pathology)
|